GlassScriptPhysician profile
Scott J Pusateri
NPI 1538139563
$1,988.94
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $731 · 2020: $587 · 2021: $556 · 2022: $115.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $361.03 | 2019-2022 | |
| Novo Nordisk INC | $245.77 | 2019-2022 | |
| Amgen INC. | $182.13 | 2019-2022 | |
| Astrazeneca Pharmaceuticals LP | $164.32 | 2019-2021 | |
| Pfizer INC. | $128.07 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $115.74 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $76.60 | 2020-2021 | |
| Avanir Pharmaceuticals, INC. | $74.89 | 2019 | |
| Janssen Pharmaceuticals, INC | $74.37 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $73.57 | 2019-2021 | |
| Lilly USA, LLC | $73.49 | 2019-2021 | |
| Allergan, INC. | $67.34 | 2019-2020 | |
| Kowa Pharmaceuticals America, INC. | $66.99 | 2019-2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $54.48 | 2019-2021 | |
| Amarin Pharma, INC. | $50.11 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $48.92 | 2021-2022 | |
| Astellas Pharma US INC | $44.01 | 2019-2020 | |
| Abbvie INC. | $43.53 | 2021 | |
| Biohaven Pharmaceuticals, INC. | $29.73 | 2021 | |
| Cardiovascular Systems INC. | $13.85 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Pusateri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.